ProductsDistribution Products

INTRATECT

Therapeutic indication:

Replacement therapy in adults, and children and adolescents (0-18 years) in:

  • Primary immunodeficiency syndromes with impaired antibody production.
  • Hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic leukaemia, inwhom prophylactic antibiotics have failed.
  • Hypogammaglobulinaemia and recurrent bacterial infections in plateau phase multiple myeloma patients whohave failed to respond to pneumococcal immunisation.
  • Hypogammaglobulinaemia in patients after allogeneic haematopoietic stem cell transplantation (HSCT).
  • Congenital AIDS with recurrent bacterial infections.

Immunomodulation in adults, and children and adolescents (0-18 years) in:

  • Primary immune thrombocytopenia (ITP), in patients at high risk of bleeding or prior to surgery to correct theplatelet count.
  • Guillain Barré syndrome.
  • Kawasaki disease.
  • Composition: Immunoglobulin normal human 50 g/L , 100 g/L
  • Pharmaceutical form: Solution for infusion
  • Method of administration: intravenous
  • Manufacturer: Biotest